- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Carfilzomib, Lenalidomide, Dexamethasone, Belantamab Mafodotin
Total 500 results
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
AmgenTerminated
-
M.D. Anderson Cancer CenterBristol-Myers SquibbWithdrawnMultiple Myeloma | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
-
Hoffmann-La RocheCompleted
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Korea, Republic of, Czechia, Israel, Switzerland, Belgium, United Kingdom, Japan, Canada, Spain, Sweden, Germany, Australia, Netherlands, France, Argentina, Brazil, Denmark, Greece, Poland, Ireland, Hungary, Portugal, F... and more
-
University of Turin, ItalyRecruiting
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbTerminatedMultiple MyelomaUnited States
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Spain
-
Juan DuRecruitingMultiple MyelomaChina
-
University of LeedsCelgene; Janssen, LP; Myeloma UKActive, not recruiting
-
Weill Medical College of Cornell UniversityCelgene CorporationTerminated
-
AmgenInnovative Therapies For Children with Cancer Consortium; Therapeutic Advances...Active, not recruitingAcute Lymphoblastic Leukemia (ALL)Spain, United Kingdom, United States, Korea, Republic of, Czechia, France, Russian Federation, Saudi Arabia, Thailand, Canada, Italy, Singapore, Turkey, Taiwan, Portugal, Poland, Romania, Brazil, Australia, Greece, Argentina, Mexico, Austr... and more
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
Stichting European Myeloma NetworkJanssen Research & Development, LLCRecruitingMultiple MyelomaNetherlands, United States, Spain, Belgium, France, Italy, Germany, Japan, Canada, Australia, Sweden, Israel, United Kingdom, Czechia, Greece, Switzerland, Norway
-
PETHEMA FoundationCabyc, S.L.Active, not recruiting
-
M.D. Anderson Cancer CenterNovartisCompleted
-
National Cancer Institute (NCI)Active, not recruitingCutaneous T-Cell Lymphoma | Peripheral T-Cell Lymphoma | Mature T-cell Malignancies | Relapsed/ Refractory T-cell MalignanciesUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); Millennium... and other collaboratorsActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Sun Yat-sen UniversityChina Food and Drug AdministrationWithdrawnRelapse/Refractory Multiple MyelomaChina
-
Emory UniversityNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCRecruitingRenal Failure | Plasma Cell MyelomaUnited States
-
Swiss Group for Clinical Cancer ResearchTerminatedMultiple MyelomaSwitzerland, Italy
-
Vejle HospitalThe University of Hong KongCompleted
-
GenmabAbbVieRecruitingFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, France, Italy, Spain, United Kingdom, Belgium, Denmark, Netherlands, Finland, Czechia, Sweden, Australia, Norway
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene Corporation; Ortho Biotech Clinical Affairs, L.L.C.CompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Barbara Ann Karmanos Cancer InstituteBristol-Myers Squibb; National Cancer Institute (NCI); Multiple Myeloma Research...Active, not recruitingRecurrent Primary AmyloidosisUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | CCND1 Positive | CD20-Positive Neoplastic Cells Present
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Millennium Pharmaceuticals, Inc.TerminatedRelapsed or Refractory Systemic Light Chain AmyloidosisUnited States, Canada, Spain, Israel, France, Australia, Denmark, Germany, Korea, Republic of, Greece, Netherlands, Brazil, Czechia, Italy, United Kingdom
-
CelgeneWithdrawnLymphoma, B-CellKorea, Republic of, United States, Spain, Belgium, Taiwan, United Kingdom, Austria, France
-
PrECOG, LLC.CelgeneTerminatedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
Carl Ola Landgren, MD, PhDBristol-Myers SquibbRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationActive, not recruitingPlasma Cell Myeloma | Residual DiseaseUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...TerminatedMultiple MyelomaUnited States
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Withdrawn
-
M.D. Anderson Cancer CenterWithdrawn
-
SanofiNot yet recruiting
-
OncotherapeuticsCelgene CorporationTerminatedMultiple MyelomaUnited States
-
Gesellschaft fur Medizinische Innovation - Hamatologie...Celgene; AmgenTerminatedDiffuse Large B-cell Lymphoma (DLBCL) | Burkitt Lymphoma (BL) | Follicular Lymphoma Grade III (FL III°) | Mantle Cell Lymphoma (MCL), Blastoid Variant | Aggressive Marginal Zone Lymphoma (MZL)Germany
-
Columbia UniversityCompletedMultiple MyelomaUnited States
-
Institute of Hematology & Blood Diseases HospitalRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed LymphomaChina
-
Mayo ClinicRecruiting
-
National Cancer Institute (NCI)Recruiting
-
Robert Redner, MDCephalonCompleted
-
Mehrdad Abedi, MDAmgenCompletedStage IV Adult Lymphoblastic Lymphoma | Contiguous Stage II Adult Lymphoblastic Lymphoma | Noncontiguous Stage II Adult Lymphoblastic Lymphoma | Stage I Adult Lymphoblastic Lymphoma | Stage III Adult Lymphoblastic Lymphoma | Untreated Adult Acute Lymphoblastic LeukemiaUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
M.D. Anderson Cancer CenterCelgene CorporationTerminated